Abstract: In one or more embodiments, a system and/or a method may implement: receiving data representing different performance behavior metrics that are associated with software instances that are respectively associated with consumer computers and that specify values of performance factors of the software instances as the consumer computers interoperate with the software instances; determining data throughput values that represent processing throughput of the software instances; determining relative capacity values of the software instances; adapting each of prediction models to the relative capacity values; determining correlation coefficients from the prediction models and the multiple data throughput values; executing a prediction model of the prediction models associated with a particular correlation coefficient closest to result in outputting threshold values associated with the performance factors; and transmitting the threshold values to a particular consumer computer among the consumer computers as part of a

Abstract: Provided is a smart safety regulation system of Ringer solution, which includes: a regulator body having a body frame; a lower roller rotatably disposed inside the body frame; a flow regulating roller rotatably disposed inside the body frame and apart from an upper surface of the lower roller wherein a portion of an outer periphery of the flow regulating roller protrudes through an open upper side of the body frame; and a safety cover which accommodates the regulator body detachably. The system has an effect that a flow of the Ringer solution will not change even if a patient misoperates or does not operate skillfully in order to prevent medical accidents.

Abstract: The present invention provides cell-targeting molecules which can deliver a CD8+ T-cell epitope cargo to the MHC class I presentation pathway of the cell. The cell-targeting molecules of the invention can be used to deliver virtually any CD8+ T-cell epitope from an extracellular space to the MHC class I pathway of a target cell, which may be a malignant cell and/or non-immune cell. The target cell can then display on a cell-surface the delivered CD8+ T-cell epitope complexed with MHC I molecule. The cell-targeting molecules of the invention have uses which include the targeted labeling and/or killing of specific cell-types within a mixture of cell-types, including within a chordate, as well as the stimulation of beneficial immune responses. The cell-targeting molecules of the invention have uses, e.g., in the treatment of a variety of diseases, disorders, and conditions, including cancers, tumors, growth abnormalities, immune disorders, and microbial infections.

Abstract: The present invention provides cell-targeting molecules which can deliver a CD8+ T-cell epitope cargo to the MHC class I presentation pathway of a target cell. The cell-targeting molecules of the invention can be used to deliver virtually any CD8+ T-cell epitope from an extracellular space to the MHC class I pathway of a target cell, which may be a malignant cell and/or non-immune cell. The target cell can then display on a cell-surface the delivered CD8+ T-cell epitope complexed with MHC I molecule. The cell-targeting molecules of the invention have uses which include the targeted labeling and/or killing of specific cell-types within a mixture of cell-types, including within a chordate, as well as the stimulation of beneficial immune responses. The cell-targeting molecules of the invention have uses, e.g., in the treatment of a variety of diseases, disorders, and conditions, including cancers, tumors, growth abnormalities, immune disorders, and microbial infections.

Abstract: A wig apparatus, comprising: a mesh cap configured such that artificial hair can be coupled to an outer surface thereof; an adjustable headband comprising a first end and a second end, wherein the headband extends around at least a portion of the circumference of the mesh cap; an elastic band extending around an entire circumference of the mesh cap; and wherein the headband is coupled to at least a portion of one of the mesh cap and the elastic band.

Abstract: The present invention provides proteins comprising binding regions for cell-type specific targeting, Shiga toxin effector regions derived from A Subunits of members of the Shiga toxin family for providing Shiga toxin effector functions (e.g. cellular internalization and cytotoxicity), and carboxy-terminal endoplasmic reticulum localization signal motifs. The presently disclosed proteins can comprise additional exogenous materials, such as, e.g., antigens, cytotoxic agents, and detection-promoting agents, and are capable of targeted delivery of these additional exogenous materials into the interiors of target cells. The proteins of the present invention have uses in methods such as, e.g., methods involving targeted killing of target cells, delivering exogenous materials into target cells, labeling subcellular compartments of target cells, and diagnosing and/or treating a variety of conditions including cancers, tumors, other growth abnormalities, immune disorders, and microbial infections.

Abstract: The present invention provides cell-targeting molecules which can deliver a CD8+ T-cell epitope cargo to the MHC class I presentation pathway of a target cell. The cell-targeting molecules of the invention can be used to deliver virtually any CD8+ T-cell epitope from an extracellular space to the MHC class I pathway of a target cell, which may be a malignant cell and/or non-immune cell. The target cell can then display on a cell-surface the delivered CD8+ T-cell epitope complexed with MHC I molecule. The cell-targeting molecules of the invention have uses which include the targeted labeling and/or killing of specific cell-types within a mixture of cell-types, including within a chordate, as well as the stimulation of beneficial immune responses. The cell-targeting molecules of the invention have uses, e.g., in the treatment of a variety of diseases, disorders, and conditions, including cancers, tumors, growth abnormalities, immune disorders, and microbial infections.

Abstract: In one or more embodiments, a system and/or a method may implement: receiving data representing different performance behavior metrics that are associated with software instances that are respectively associated with consumer computers and that specify values of performance factors of the software instances as the consumer computers interoperate with the software instances; determining data throughput values that represent processing throughput of the software instances; determining relative capacity values of the software instances; adapting each of prediction models to the relative capacity values; determining correlation coefficients from the prediction models and the multiple data throughput values; executing a prediction model of the prediction models associated with a particular correlation coefficient closest to result in outputting threshold values associated with the performance factors; and transmitting the threshold values to a particular consumer computer among the consumer computers as part of a

Abstract: A hair extension apparatus includes: a first base member comprising a first front edge, a first rear edge, a first side edge, a first top surface and a first bottom surface; a second base member comprising a second front edge, a second rear edge, a second side edge, a second top surface and a second bottom surface, wherein the second base member is coupled to the first base member; a first artificial hair section comprising artificial hair, wherein the first artificial hair section is coupled to the first top surface of the first base member; and a second artificial hair section comprising artificial hair, wherein the second artificial hair section is coupled to the second top surface of the second base member.

Abstract: In one or more embodiments, a system and/or a method may implement: receiving data representing different performance behavior metrics that are associated with software instances that are respectively associated with consumer computers and that specify values of performance factors of the software instances as the consumer computers interoperate with the software instances; determining data throughput values that represent processing throughput of the software instances; determining relative capacity values of the software instances; adapting each of prediction models to the relative capacity values; determining correlation coefficients from the prediction models and the multiple data throughput values; executing a prediction model of the prediction models associated with a correlation coefficient closest to a value of “1” to result in outputting threshold values associated with the performance factors; and transmitting the threshold values to a particular consumer computer among the consumer computers as par

Abstract: A hair extension apparatus, comprising: a first base member comprising a first front edge, a first rear edge, a first side edge, a first top surface and a first bottom surface; a second base member comprising a second front edge, a second rear edge, a second side edge, a second top surface and a second bottom surface, wherein the second base member is coupled to the first base member; a first artificial hair section comprising artificial hair, wherein the first artificial hair section is coupled to the first top surface of the first base member; a second artificial hair section comprising artificial hair, wherein the second artificial hair section is coupled to the second top surface of the second base member; and a first fastener member coupled to the first side edge on the first bottom surface of the first base member.

Abstract: Provided herein are multivalent CD20-binding molecules, and compositions thereof, for use in selective killing of specific cell types and/or as therapeutics for the treatment of a variety of diseases, including cancer, tumors, and immune disorders. Certain multivalent CD20-binding molecules can be used to deliver agents into CD20-expressing cells, collecting diagnostic information, and/or monitoring the treatment of diseases, such as cancers, tumors, and immune disorders.

Abstract: A server computer receives configuration data from a first user of a first user device and establishes an interaction limit for the first user based on the configuration data. The server computer subsequently receives a request message from a second user device of a second user that includes parameters, including a request for services. The server computer selects the first user from a plurality of users based on the parameters and the configuration data from the first user. The server computer transmits a quote message to the second user device indicating the selection of the first user and including a quote. When the server computer receives an indication of a response message from the second user device, the server computer processes the response message and determines if the response message is indicative of an interaction type that requires modifying a first user account associated with the first user.

Abstract: A GUI and processor-based method for managing selectable entities such as files and directories. When the number of selectable entities in the GUI is large (e.g. over 50 entities) or if similar operations must be done repeatedly, the user experience can be drastically improved by generating and operating on sets of selectable entities. Users (such as a human user) start by picking a plurality of entities displayed on the GUI and save them in memory as a named selection set. Users operate the GUI to manipulate any such selection sets via various means (such as intersection, union, inversion/negation, or via user defined programs) until a selection set contains only the entities that the user wishes to operate on. The user then directs the GUI to automatically perform any of memory/storage operations and/or network transmission operations upon any files and directories in the selection set as desired.

Abstract: The present invention provides CD20-binding proteins that bind to and rapidly internalize in a CD20-mediated fashion from a cell surface location to the interior of the cell. CD20-binding proteins of the invention comprise a CD20 binding region and a Shiga toxin effector region. Certain of the disclosed CD20-binding proteins kill cells that express CD20 on their surface. Further, the presently disclosed CD20-binding proteins can comprise additional exogenous materials, such as, e.g., antigens, and are capable of targeted delivery of these additional exogenous materials into the interior of CD20 expressing cells. These CD20-binding proteins have uses in methods such as, e.g.

Abstract: Hash operations on large computer files can be relatively slow, but are needed to ensure accurate computer file transmission. The present disclosure covers a system and method to accelerate the process of making hash verified network copies of digital assets (computer files), and is particularly useful in handing computer files that were previously unknown to the file system (e.g. no prior hash values were computed). The system operates by analyzing the computer file into smaller parts, each with a part-offset relative to the parts' position in the original computer file, and generating the hash of the parts simultaneously with the entire computer file hash. The system can commence various network write operations when only a single part hash is available and does not need to wait for a complete computer file hash to be computed. This enables the burden of file transfers to be handled by multiple network peer computers.

Abstract: The present invention provides cell-targeting molecules which can deliver a CD8+ T-cell epitope cargo to the MHC class I presentation pathway of a target cell. The cell-targeting molecules of the invention can be used to deliver virtually any CD8+ T-cell epitope from an extracellular space to the MHC class I pathway of a target cell, which may be a malignant cell and/or non-immune cell. The target cell can then display on a cell-surface the delivered CD8+ T-cell epitope complexed with MHC I molecule. The cell-targeting molecules of the invention have uses which include the targeted labeling and/or killing of specific cell-types within a mixture of cell-types, including within a chordate, as well as the stimulation of beneficial immune responses. The cell-targeting molecules of the invention have uses, e.g., in the treatment of a variety of diseases, disorders, and conditions, including cancers, tumors, growth abnormalities, immune disorders, and microbial infections.

Abstract: The present invention provides multivalent CD20-binding molecules and compositions thereof, such as enriched compositions comprising large proportions of multivalent CD20-binding molecules relative to monovalent CD20-binding molecules. Certain multivalent CD20-binding molecules of the present invention comprise (i) two or more CD20-binding regions and (ii) one or more Shiga toxin effector polypeptide regions derived from an A Subunit of a member of the Shiga toxin family. Certain multivalent CD20-binding molecules of the present invention, and compositions thereof, have uses for selective killing of specific cell types and as therapeutics for the treatment of a variety of diseases, including cancers, tumors, and immune disorders.

Abstract: A hair extension apparatus, comprising: a first base member comprising a first front edge, a first rear edge, a first side edge, a first top surface and a first bottom surface; a second base member comprising a second front edge, a second rear edge, a second side edge, a second top surface and a second bottom surface, wherein the second base member is coupled to the first base member; a first artificial hair section comprising artificial hair, wherein the first artificial hair section is coupled to the first top surface of the first base member; a second artificial hair section comprising artificial hair, wherein the second artificial hair section is coupled to the second top surface of the second base member; and a first fastener member coupled to the first side edge on the first bottom surface of the first base member.

Abstract: A wig apparatus is provided. The wig apparatus includes: a mesh base comprising an inner surface, an outer surface, a fold portion and a terminal edge portion; a band member comprising a first surface, a second surface, a top edge and a bottom edge, wherein the first surface is coupled to the inner surface of the mesh base and wherein the second surface is coupled to the inner surface of the mesh base; a first portion of artificial hair coupled to at least the outer surface of the mesh base adjacent to the first surface; and a second portion of artificial hair coupled to the outer surface of the mesh base adjacent to the second surface.